CRIS Competitors & Alternatives
Compare Curis Inc with similar stocks in the same industry
Biotechnology
CRIS
Main Stock$0.45
Tradestie Score
41
Market Cap
$20.87M
P/E Ratio
0.4
Revenue Growth
-0.7%
Analyst Upside
+9488.0%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.15
|
$199.71M | - | 51 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.24
|
$154.27M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.36
|
$133.50M | - | 31 | Compare |
|
AGEN
Agenus Inc.
|
$6.73
|
$124.27M | 29.9 | 50 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.61
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$29.54
|
$110.20M | - | 35 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.11
|
$84.52M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.84
|
$67.94M | - | 52 | Compare |
More CRIS Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2836)
217 stocks in this industry